Mr. Chris E. Piercy

• 
  About Us - [Cached Version]
  Published on: 6/1/2003    Last Visited: 4/23/2008  

  Chris E. Piercy
  
  Chris Piercy is an experienced investor, entrepreneur, and
  ...
  Mr. Piercy has been working in the biotechnology sector since 1985, when he joined the pioneering biotechnology company, Cetus Corporation (now Chiron; NASDAQ 'CHIR').Mr. Piercy has been a partner at SVIC , a Palo Alto based early stage venture capital firm.
  
  Chris Piercy studied Molecular Genetics and History at U.C. Berkeley and business at Harvard Business School, and the Stanford Business School Advanced Management Program.Mr. Piercy serves as an Advisory board member of NASA Ames Institute of Science and Technology (NAIST); serves on the Advisory Board for the University of California Center for Adaptive Optics; industry advisory board for the National Science Foundation Center for Biophotonics Science and Technology (CBST).Chris Piercy is also a founding board member of the Silicon Valley Nanobiotechnology
  ...
  Mr. Piercy is an author of a number of studies and books on biotechnology and nanotechnology.He is the inventor of developing or patented technologies and his scientific

• 
  Action International - Company - [Cached Version]
  Published on: 7/31/2005    Last Visited: 7/31/2005  

  Mr. Christopher Piercy- has over 20 years of executive level success with developing and managing international sales channels in the life sciences / biopharmaceutical / nanotechnology sectors.As CEO of Genmetrics, Cytogene Pharmaceuticals, Bioselectex, and others, he led these companies' sales efforts in over 110 countries.Previously, Mr. Piercy had spearheaded and developed sales and business development efforts that had, for example, increased international sales by over 10x in a one year period for one company, opened new and profitable markets and channels before products were even developed that actually funded final product development, at another.He developed his sales and business development skills during his work at Cetus Corporation (now Chiron; NASDAQ "CHIR"; Connetics, (NASDAQ "CNCT"; Intermune Pharmaceuticals NASDAQ "ITMN", Zeria Pharmaceuticals (Japan SE), and others.Additionally, Mr. Piercy was a management consultant at Coleman Consulting, a operations consulting firm for Global Fortune 500, for ten years.

• 
  All Bright - [Cached Version]
  Published on: 11/16/2002    Last Visited: 11/11/2004  

  Dr. Chris Piercy, Chairman of Northern California Nanothechnology Initiative chaired the meeting at the US site at Standford Universtiy. nine 9 scientists from Shanghai and Silicon Valley delivered speeches at the forum, and all the expertise had a hot discussion. on the development of Nano-technology and cooperation in this field.

• 
  BioExchange - Life Sciences and Biotechnology Resource... - [Cached Version]
  Published on: 2/12/2002    Last Visited: 2/27/2002  

  William Musgrave\r\n650 Saratoga Avenue\r\nSan Jose, CA 95129\r\nTel: 4085576820\r\nFax: 4085576797\r\nEmail: bill@tennet.org\r\n\r\nGenMetrics\r\nChris Piercy, Chief Executive Officer\r\n650 Saratoga Avenue\r\nSan Jose, CA 95129\r\nTel: 4085576768\r\nFax: 4085576799\r\nEmail: chrisp@gnmetrics.com\r\n
  
  \r\n
  
  \r\nContact:\r\n
  
  The Enterprise Network of Silicon Valley\r\n
  
  ...
  ``With the new resources now available to us, GenMetrics will be better able to further develop our portfolio of novel drug target candidates, both independently and in cooperation with major pharmaceutical and biotechnology firms,'' stated Chris Piercy, GenMetrics Chief Executive Officer.

• 
  Ceilidh ... The Northern California Nanotechnology... - [Cached Version]
  Published on: 6/18/2003    Last Visited: 3/28/2006  

  "Nanotechnology is at the inflection point and NCnano provides much needed coordination and infrastructure for the dynamic and rapidly growing nanotechnology cluster in the Bay Area," said Chris Piercy, Chairman of the NCnano.

• 
  ClearSpeed : Press Releases - [Cached Version]
  Published on: 10/14/2003    Last Visited: 8/15/2005  

  "To deliver such high levels of performance with full programmability and outstanding gains in power efficiency is a very significant achievement," said Chris Piercy, president and chairman of the Northern California Nanotechnology Initiative.

• 
  EE Times - NCnano Launches First in Series of... - [Cached Version]
  Published on: 6/18/2003    Last Visited: 6/19/2003  

  "Nanotechnology is at the inflection point and NCnano provides much needed coordination and infrastructure for the dynamic and rapidly growing nanotechnology cluster in the Bay Area," said Chris Piercy, Chairman of the NCnano.

• 
  GenMetrics Press Release - [Cached Version]
  Published on: 8/17/2001    Last Visited: 5/28/2002  

  "With the new resources now available to us, GenMetrics will be better able to further develop our portfolio of novel drug target candidates, both independently and in cooperation with major pharmaceutical and biotechnology firms," stated Chris Piercy, GenMetrics Chief Executive Officer.
  
  ...
  Chris Piercy, Chief Executive Officer650 Saratoga AvenueSan Jose, CA 95129Tel: 408-557-6768Fax: 408-557-6799

• 
  IndyMedia Center - webcast news - [Cached Version]
  Published on: 9/4/2003    Last Visited: 9/8/2003  

  "Entrepreneurs need to recognize they aren't going to get VC funding," said Chris Piercy, president and chairman of the Northern California Nanotechnology Initiative, a regional coordinating body.

• 
  MEMS Center.com | The World's Favorite MEMS Guide - [Cached Version]
  Published on: 8/21/2001    Last Visited: 6/5/2002  

  Chair, Steve Jurvetson, Managing Director, Draper, Fisher, Jurvetson; Peter Freudenthal, Chairman, CEO, MeVC; George Zachary, General Partner, Mohr, Davidow Ventures; Chris Piercy, Partner, Knowledge Market

Page:  1 2 3